Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 2
2020 4
2021 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy.
Ferrara R, Mezquita L, Texier M, Lahmar J, Audigier-Valette C, Tessonnier L, Mazieres J, Zalcman G, Brosseau S, Le Moulec S, Leroy L, Duchemann B, Lefebvre C, Veillon R, Westeel V, Koscielny S, Champiat S, Ferté C, Planchard D, Remon J, Boucher ME, Gazzah A, Adam J, Bria E, Tortora G, Soria JC, Besse B, Caramella C. Ferrara R, et al. Among authors: leroy l. JAMA Oncol. 2018 Nov 1;4(11):1543-1552. doi: 10.1001/jamaoncol.2018.3676. JAMA Oncol. 2018. PMID: 30193240 Free PMC article.
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer.
Mezquita L, Auclin E, Ferrara R, Charrier M, Remon J, Planchard D, Ponce S, Ares LP, Leroy L, Audigier-Valette C, Felip E, Zerón-Medina J, Garrido P, Brosseau S, Zalcman G, Mazieres J, Caramela C, Lahmar J, Adam J, Chaput N, Soria JC, Besse B. Mezquita L, et al. Among authors: leroy l. JAMA Oncol. 2018 Mar 1;4(3):351-357. doi: 10.1001/jamaoncol.2017.4771. JAMA Oncol. 2018. PMID: 29327044 Free PMC article.
Antitumor Effects of PRMT5 Inhibition in Sarcomas.
Verbeke S, Bourdon A, Guegan JP, Leroy L, Chaire V, Richard E, Bessede A, Italiano A. Verbeke S, et al. Among authors: leroy l. Cancer Res Commun. 2023 Nov 2;3(11):2211-2220. doi: 10.1158/2767-9764.CRC-23-0239. Cancer Res Commun. 2023. PMID: 37861293 Free PMC article.
ATRX Alteration Contributes to Tumor Growth and Immune Escape in Pleomorphic Sarcomas.
Darmusey L, Pérot G, Thébault N, Le Guellec S, Desplat N, Gaston L, Delespaul L, Lesluyes T, Darbo E, Gomez-Brouchet A, Richard E, Baud J, Leroy L, Coindre JM, Blay JY, Chibon F. Darmusey L, et al. Among authors: leroy l. Cancers (Basel). 2021 Apr 29;13(9):2151. doi: 10.3390/cancers13092151. Cancers (Basel). 2021. PMID: 33946962 Free PMC article.
Medium levels of transcription and replication related chromosomal instability are associated with poor clinical outcome.
Benhaddou A, Gaston L, Pérot G, Desplat N, Leroy L, Le Guellec S, Ben Haddou M, Rochaix P, Valentin T, Ferron G, Chevreau C, Bui B, Stoeckle E, Le Cesne A, Piperno-Neumann S, Collin F, Firmin N, De Pinieux G, Coindre JM, Blay JY, Chibon F. Benhaddou A, et al. Among authors: leroy l. Sci Rep. 2021 Dec 6;11(1):23429. doi: 10.1038/s41598-021-02787-x. Sci Rep. 2021. PMID: 34873180 Free PMC article.
Distinct Cellular Origins and Differentiation Process Account for Distinct Oncogenic and Clinical Behaviors of Leiomyosarcomas.
Darbo E, Pérot G, Darmusey L, Le Guellec S, Leroy L, Gaston L, Desplat N, Thébault N, Merle C, Rochaix P, Valentin T, Ferron G, Chevreau C, Bui B, Stoeckle E, Ranchere-Vince D, Méeus P, Terrier P, Piperno-Neumann S, Collin F, De Pinieux G, Duffaud F, Coindre JM, Blay JY, Chibon F. Darbo E, et al. Among authors: leroy l. Cancers (Basel). 2023 Jan 15;15(2):534. doi: 10.3390/cancers15020534. Cancers (Basel). 2023. PMID: 36672483 Free PMC article.
13 results